Rezultati - Michael Untch
- Showing 1 - 20 results of 140
- Go to Next Page
-
1
-
2
Breast Reconstruction Following Cancer Treatment od Bernd Gerber, Mario Marx, Michael Untch, Andreé Faridi
Izdano 2015Errata/Corrigenda -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance od Thorsten Kuehn, A. Bembenek, Thomas Decker, D. L. Munz, Marie‐Luise Sautter‐Bihl, Michael Untch, D. Wallwiener
Izdano 2004Revisão -
11
-
12
The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer od Oumar Camara, Matthias Rengsberger, A Egbe, André Koch, Mieczysław Gajda, Ulrike Hammer, Cornelia Jörke, C. Rabenstein, Michael Untch, Katharina Pachmann
Izdano 2007Artigo -
13
Impact of updated HER2 testing guidelines in breast cancer—re-evaluation of HERA trial fluorescence in situ hybridization data od Oliver Stoß, Andreas H. Scheel, Iris Nagelmeier, Hans‐Ulrich Schildhaus, Thomas Henkel, Giuseppe Viale, Bharat Jasani, Michael Untch, Josef Rüschoff
Izdano 2015Artigo -
14
-
15
Phase I Trial of the Trifunctional Anti-HER2 × Anti-CD3 Antibody Ertumaxomab in Metastatic Breast Cancer od Philipp Kiewe, Stephan Hasmüller, Steffen Kahlert, M Heinrigs, Brigitte Rack, Alexander Marmé, Agnieszka Korfel, Michael Jäger, Horst Lindhofer, Harald Sommer, Eckhard Thiel, Michael Untch
Izdano 2006Artigo -
16
Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibit... od F. Jänicke, A. Prechtl, Christoph Thomssen, Nadia Harbeck, Christoph Meisner, Michael Untch, Fred C.G.J. Sweep, H. K. Selbmann, H. Graeff, Manfred Schmitt
Izdano 2001Artigo -
17
Leuprorelin Acetate Every-3-Months Depot Versus Cyclophosphamide, Methotrexate, and Fluorouracil As Adjuvant Treatment in Premenopausal Patients With Node-Positive Breast Cancer: T... od Peter Schmid, Michael Untch, V. A. Kosse, Grigorij Bondar, Leonid Vassiljev, V I Tarutinov, Ute Lehmann, L. Maubach, Juergen Meurer, D. Wallwiener, Kurt Possinger
Izdano 2007Artigo -
18
HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer od Nadia Harbeck, Matthias W. Beckmann, Achim Rody, Andreas Schneeweiß, Volkmar Müller, Tanja Fehm, Norbert Marschner, Oleg Gluz, Iris Schrader, Georg Heinrich, Michael Untch, Christian Jackisch
Izdano 2013Revisão -
19
Monitoring Primary Systemic Therapy of Large and Locally Advanced Breast Cancer by Using Sequential Positron Emission Tomography Imaging With [<sup>18</sup>F]Fluorodeoxyglucose od Jörg Schwarz-Dose, Michael Untch, Reinhold Tiling, Stefanie Sassen, Sven� Mahner, Steffen Kahlert, Nadia Harbeck, Annette Lebeau, Winfried Brenner, Markus Schwaiger, Fritz Jaenicke, Norbert Avril
Izdano 2008Artigo -
20
Effect of Once-Weekly Epoetin Beta on Survival in Patients With Metastatic Breast Cancer Receiving Anthracycline- and/or Taxane-Based Chemotherapy: Results of the Breast Cancer—Ane... od Matti Aapro, Robert Leonard, Agustí Barnadas, M. Marangolo, Michael Untch, Nikolaos Malamos, José Mayordomo, Dietmar Reichert, José Luiz Pedrini, Lidia Ukarma, Armin Scherhag, Hans-Ulrich Burger
Izdano 2008Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Cancer
Breast cancer
Oncology
Chemotherapy
Trastuzumab
Biology
Neoadjuvant therapy
Epirubicin
Taxane
Confidence interval
Gynecology
Metastatic breast cancer
Hazard ratio
Pathology
Surgery
Gastroenterology
Lapatinib
Cyclophosphamide
Triple-negative breast cancer
Anthracycline
Clinical endpoint
Randomized controlled trial
Clinical trial
Adjuvant
Genetics
Biochemistry
Gene
Cancer research